The CD163+ macrophages infiltration density in BMB samples of CML patients was increased significantly higher than that of the control group (2.71 ± 0.82)% (P < 0.01). The gene discussed is CD163; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.